Revance Therapeutics Statistics
Total Valuation
ESOA has a market cap or net worth of $169.69 million. The enterprise value is $212.97 million.
| Market Cap | 169.69M |
| Enterprise Value | 212.97M |
Important Dates
The next estimated earnings date is Tuesday, August 19, 2025, after market close.
| Earnings Date | Aug 19, 2025 |
| Ex-Dividend Date | Jul 3, 2025 |
Share Statistics
ESOA has 16.72 million shares outstanding. The number of shares has decreased by -0.12% in one year.
| Current Share Class | 16.72M |
| Shares Outstanding | 16.72M |
| Shares Change (YoY) | -0.12% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 26.13% |
| Owned by Institutions (%) | 40.67% |
| Float | 12.35M |
Valuation Ratios
The trailing PE ratio is 9.32.
| PE Ratio | 9.32 |
| Forward PE | n/a |
| PS Ratio | 0.46 |
| Forward PS | 0.43 |
| PB Ratio | 3.16 |
| P/TBV Ratio | 3.99 |
| P/FCF Ratio | 9.31 |
| P/OCF Ratio | 5.96 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.00, with an EV/FCF ratio of 11.68.
| EV / Earnings | 11.68 |
| EV / Sales | 0.58 |
| EV / EBITDA | 10.00 |
| EV / EBIT | 19.66 |
| EV / FCF | 11.68 |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.99.
| Current Ratio | 1.31 |
| Quick Ratio | 1.24 |
| Debt / Equity | 0.99 |
| Debt / EBITDA | 1.40 |
| Debt / FCF | 2.92 |
| Interest Coverage | 4.66 |
Financial Efficiency
Return on equity (ROE) is 41.26% and return on invested capital (ROIC) is 7.12%.
| Return on Equity (ROE) | 41.26% |
| Return on Assets (ROA) | 4.42% |
| Return on Invested Capital (ROIC) | 7.12% |
| Return on Capital Employed (ROCE) | 11.98% |
| Revenue Per Employee | $263,547 |
| Profits Per Employee | $13,057 |
| Employee Count | 1,396 |
| Asset Turnover | 2.40 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ESOA has paid $5.98 million in taxes.
| Income Tax | 5.98M |
| Effective Tax Rate | 24.70% |
Stock Price Statistics
The stock price has increased by +51.72% in the last 52 weeks. The beta is 0.93, so ESOA's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | +51.72% |
| 50-Day Moving Average | 10.28 |
| 200-Day Moving Average | 11.15 |
| Relative Strength Index (RSI) | 48.59 |
| Average Volume (20 Days) | 180,659 |
Short Selling Information
The latest short interest is 1.14 million, so 6.79% of the outstanding shares have been sold short.
| Short Interest | 1.14M |
| Short Previous Month | 1.09M |
| Short % of Shares Out | 6.79% |
| Short % of Float | 9.19% |
| Short Ratio (days to cover) | 4.45 |
Income Statement
In the last 12 months, ESOA had revenue of $367.91 million and earned $18.23 million in profits. Earnings per share was $1.09.
| Revenue | 367.91M |
| Gross Profit | 43.22M |
| Operating Income | 10.83M |
| Pretax Income | 33.10M |
| Net Income | 18.23M |
| EBITDA | 21.29M |
| EBIT | 10.83M |
| Earnings Per Share (EPS) | $1.09 |
Balance Sheet
The company has $9.93 million in cash and $53.21 million in debt, giving a net cash position of -$43.28 million or -$2.59 per share.
| Cash & Cash Equivalents | 9.93M |
| Total Debt | 53.21M |
| Net Cash | -43.28M |
| Net Cash Per Share | -$2.59 |
| Equity (Book Value) | 53.78M |
| Book Value Per Share | 3.22 |
| Working Capital | 24.40M |
Cash Flow
In the last 12 months, operating cash flow was $28.48 million and capital expenditures -$10.26 million, giving a free cash flow of $18.23 million.
| Operating Cash Flow | 28.48M |
| Capital Expenditures | -10.26M |
| Free Cash Flow | 18.23M |
| FCF Per Share | $1.09 |
Margins
Gross margin is 11.75%, with operating and profit margins of 2.94% and 4.95%.
| Gross Margin | 11.75% |
| Operating Margin | 2.94% |
| Pretax Margin | 6.58% |
| Profit Margin | 4.95% |
| EBITDA Margin | 5.79% |
| EBIT Margin | 2.94% |
| FCF Margin | 4.95% |
Dividends & Yields
This stock pays an annual dividend of $0.12, which amounts to a dividend yield of 1.20%.
| Dividend Per Share | $0.12 |
| Dividend Yield | 1.20% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 8.27% |
| Buyback Yield | 0.12% |
| Shareholder Yield | 1.30% |
| Earnings Yield | 10.74% |
| FCF Yield | 10.74% |
Analyst Forecast
The average price target for ESOA is $21.00, which is 106.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.00 |
| Price Target Difference | 106.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ESOA has an Altman Z-Score of 3.32 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.32 |
| Piotroski F-Score | 5 |